Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3094% above fair value
$86.06−2.59 (-2.92%)
Close on Nov 17, 2026Market cap $14.65BP/E 96.7Yield –
Solventum operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Solventum's operating cash flow for the twelve months ending Sep 30, 2026 was $310.00M, down 37.1% year over year. For fiscal 2025 it was $369.00M, down 68.9% from the year before.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $369.00M | -68.9% |
| FY2024 | Dec 31, 2024 | $1.19B | -38.1% |
| FY2023 | Dec 31, 2023 | $1.92B | +14.1% |
| FY2022 | Dec 31, 2022 | $1.68B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $177.00M | +132.9% |
| Q2 FY2026 | Jun 30, 2026 | $227.00M | +34.3% |
| Q1 FY2026 | Mar 31, 2026 | -$189.00M | -751.7% |
| Q4 FY2025 | Dec 31, 2025 | $95.00M | -56.6% |
| Q3 FY2025 | Sep 30, 2025 | $76.00M | -55.0% |
| Q2 FY2025 | Jun 30, 2025 | $169.00M | -52.4% |
| Q1 FY2025 | Mar 31, 2025 | $29.00M | -93.4% |
| Q4 FY2024 | Dec 31, 2024 | $219.00M | -60.0% |
| Q3 FY2024 | Sep 30, 2024 | $169.00M | -65.7% |
| Q2 FY2024 | Jun 30, 2024 | $355.00M | -3.0% |
| Q1 FY2024 | Mar 31, 2024 | $442.00M | -13.2% |
| Q4 FY2023 | Dec 31, 2023 | $547.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $493.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $366.00M | – |
| Q1 FY2023 | Mar 31, 2023 | $509.00M | – |
See a number that looks wrong?